Hutter & Schrantz Stahlbau AG
VSE:HST
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hutter & Schrantz Stahlbau AG
VSE:HST
|
AT |
|
Organogenesis Holdings Inc
NASDAQ:ORGO
|
US |
|
IIFL Capital Services Ltd
NSE:IIFLCAPS
|
IN |
|
AMG Advanced Metallurgical Group NV
LSE:0LO9
|
NL |
|
S
|
Suzhou Oriental Semiconductor Co Ltd
SSE:688261
|
CN |
|
Medprin Regenerative Medical Technologies Co Ltd
SZSE:301033
|
CN |
Balance Sheet
Balance Sheet Decomposition
Hutter & Schrantz Stahlbau AG
Hutter & Schrantz Stahlbau AG
Balance Sheet
Hutter & Schrantz Stahlbau AG
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
25
|
27
|
22
|
15
|
17
|
14
|
11
|
11
|
15
|
16
|
|
| Cash |
25
|
27
|
22
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
15
|
17
|
14
|
11
|
11
|
15
|
16
|
|
| Total Receivables |
30
|
25
|
30
|
34
|
19
|
20
|
21
|
10
|
12
|
14
|
|
| Accounts Receivables |
11
|
11
|
18
|
34
|
16
|
16
|
18
|
8
|
4
|
8
|
|
| Other Receivables |
19
|
14
|
12
|
0
|
3
|
4
|
3
|
2
|
7
|
6
|
|
| Inventory |
5
|
6
|
7
|
7
|
25
|
26
|
16
|
22
|
24
|
22
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
61
|
59
|
58
|
56
|
61
|
60
|
48
|
43
|
52
|
51
|
|
| PP&E Net |
13
|
16
|
16
|
16
|
17
|
19
|
21
|
23
|
23
|
27
|
|
| PP&E Gross |
13
|
16
|
16
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
20
|
21
|
23
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
2
|
1
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
|
| Goodwill |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
2
|
|
| Other Long-Term Assets |
1
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Assets |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
75
N/A
|
79
+6%
|
80
+1%
|
78
-2%
|
82
+5%
|
83
+2%
|
72
-13%
|
69
-5%
|
80
+15%
|
82
+2%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
10
|
4
|
5
|
14
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
2
|
2
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
0
|
3
|
1
|
2
|
2
|
4
|
3
|
4
|
3
|
|
| Other Current Liabilities |
9
|
10
|
7
|
1
|
12
|
11
|
11
|
9
|
15
|
18
|
|
| Total Current Liabilities |
22
|
16
|
18
|
16
|
14
|
13
|
15
|
12
|
19
|
21
|
|
| Long-Term Debt |
7
|
16
|
16
|
15
|
14
|
13
|
1
|
2
|
1
|
2
|
|
| Deferred Income Tax |
0
|
0
|
0
|
1
|
5
|
4
|
3
|
3
|
3
|
4
|
|
| Minority Interest |
4
|
5
|
5
|
5
|
7
|
8
|
6
|
5
|
5
|
5
|
|
| Other Liabilities |
7
|
8
|
8
|
8
|
8
|
11
|
13
|
12
|
15
|
14
|
|
| Total Liabilities |
41
N/A
|
46
+13%
|
47
+2%
|
45
-3%
|
48
+6%
|
48
-1%
|
38
-21%
|
33
-12%
|
42
+27%
|
46
+9%
|
|
| Equity | |||||||||||
| Common Stock |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Retained Earnings |
33
|
32
|
32
|
32
|
32
|
34
|
33
|
34
|
36
|
34
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
34
N/A
|
34
-2%
|
33
-1%
|
33
0%
|
34
+2%
|
36
+5%
|
35
-3%
|
36
+4%
|
38
+5%
|
36
-5%
|
|
| Total Liabilities & Equity |
75
N/A
|
79
+6%
|
80
+1%
|
78
-2%
|
82
+5%
|
83
+2%
|
72
-13%
|
69
-5%
|
80
+15%
|
82
+2%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|